{"database": "lobbying", "table": "lobbying_activities", "rows": [[2312170, "ba03d842-659c-436d-aafa-c1e775dc4c85", "Q2", "VAN SCOYOC ASSOCIATES", 39837, "ZEBRA TECHNOLOGIES CORP.", 2019, "second_quarter", "PHA", "Public Law 113-54, Drug Quality and Security Act, Drug labeling implementation", "HOUSE OF REPRESENTATIVES,SENATE", 120000, null, 0, 0, "2019-07-19T05:24:33.583000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2312170"], "units": {}, "query_ms": 0.3669220022857189, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}